Prof. Dr. ALİ KOCABAŞ

Yayın Ağı

Makaleler 20

1. COPD Should Diagnosis Match Physiology?

Studnicka M., Horner A., Sator L., Buist A. S., Lamprecht B., Zhong N., et al.

CHEST , cilt.157, sa.2, ss.473-475, 2020 (SCI-Expanded, Scopus)

2. Overdiagnosis of COPD in Subjects With Unobstructed Spirometry A BOLD Analysis

Sator L., Horner A., Studnicka M., Lamprecht B., Kaiser B., McBurnie M. A., et al.

CHEST , cilt.156, sa.2, ss.277-288, 2019 (SCI-Expanded, Scopus)

3. Asthma in the context of global alliance against respiratory diseases (GARD) in Turkey

Yorgancioglu A., Gemicioglu B., Ekinci B., Ozkan Z., Bayram H., ERGAN B., et al.

JOURNAL OF THORACIC DISEASE , cilt.10, sa.3, ss.2052-2058, 2018 (SCI-Expanded, Scopus)

4. EARLY PREDICTION OF SARCOIDOSIS PROGNOSIS WITH HLA TYPING: A 5 YEAR FOLLOW-UP STUDY

ÖZYILMAZ E., Ozturk O. G., Durmaz A., Hasan O. O., Guzelbaba B., SEYDAOĞLU G., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.35, sa.3, ss.184-191, 2018 (SCI-Expanded, Scopus)

5. The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD

Koektuerk N., GÜRGÜN A., ŞEN E., KOCABAŞ A., POLATLI M., NAYCI S., et al.

TURKISH THORACIC JOURNAL , cilt.18, sa.2, ss.57-64, 2017 (ESCI)

6. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis-authors' reply

Burney P., Kato B., Janson C., Mannino D., Studnicka M., Tan W., et al.

THORAX , cilt.69, sa.9, 2014 (SCI-Expanded)

7. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty-a BOLD analysis

Burney P., Jithoo A., Kato B., Janson C., Mannino D., Nizankowska-Mogilnicka E., et al.

THORAX , cilt.69, sa.5, 2014 (SCI-Expanded, Scopus)

8. **COULD HLA-DR B1*11 ALLELE BE A CLUE FOR PREDICTING EXTRA-PULMONARY SARCOIDOSIS?**

Ozyilmaz E., Ozturk O. G., Yunsel D., Deniz A., Hanta İ., Kuleci S., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.31, sa.2, ss.154-162, 2014 (SCI-Expanded, Scopus)

9. The relationship between systemic inflammation and vitamin D levels in COPD

KOCABAŞ A., Derinkuyu G., Ocak M. C., SEYDAOĞLU G., ÖZYILMAZ E.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded, Scopus)

10. HERMANSKY PUDLAK SYNDROME AND PULMONARY ALVEOLAR PROTEINOSIS AT THE SAME PATIENT: FIRST CASE REPORT IN THE WORLD LITERATURE

ÖZYILMAZ E., GÜNAŞTI S., KUYUCU Y., POLAT S., GÜMÜRDÜLÜ D., KULECİ S., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.30, sa.3, ss.217-220, 2013 (SCI-Expanded, Scopus)

11. Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project

Hooper R., Burney P., Vollmer W. M., McBurnie M. A., Gislason T., Tan W. C., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.39, sa.6, ss.1343-1353, 2012 (SCI-Expanded, Scopus)

12. The evaluation of latent tuberculosis in rheumatologic diseases for anti-TNF therapy: experience with 192 patients

HANTA İ., ÖZBEK S., KULECİ S., KOCABAŞ A.

CLINICAL RHEUMATOLOGY , cilt.27, sa.9, ss.1083-1086, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

13. The effect of different treatment modalities on oxidative stress in COPD

KULECİ S., HANTA İ., KOCABAŞ A., Canacankatan N.

ADVANCES IN THERAPY , cilt.25, sa.7, ss.710-717, 2008 (SCI-Expanded, Scopus)

14. Chlamydophila pneumoniae infection in adult asthmatics patients

KOCABAŞ A., AVSAR M., HANTA İ., KÖKSAL F., KULECİ S.

JOURNAL OF ASTHMA , cilt.45, sa.1, ss.39-43, 2008 (SCI-Expanded, Scopus)

15. Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNF alpha

Hanta I., Ozbek S., Kuleci S., Sert M., Kocabas A.

CLINICAL RHEUMATOLOGY , cilt.26, sa.11, ss.1867-1870, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Does the expired-air carbon monoxide level reflect the severity of inflammation in COPD?

HANTA İ., KOCABAŞ A., OLGUNUS O., SATAR S., SEYDAOĞLU G.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY , cilt.108, sa.6, ss.255-258, 2007 (SCI-Expanded, Scopus)

17. Oxidant-antioxidant balance in patients with COPD

HANTA İ., KOCABAS A., CANACANKATAN N., KULECI S., Seydaoglu G.

LUNG , cilt.184, sa.2, ss.51-55, 2006 (SCI-Expanded, Scopus)

18. Is sildenafil effective in secondary pulmonary hypertension due to systemic lupus erythematosus? A case report

Hanta I., Demir M., Akpinar O., Kocabas A., Ozbek S.

CLINICAL RHEUMATOLOGY , cilt.24, sa.6, ss.671-672, 2005 (SCI-Expanded)

19. Membranoproliferative glomerulonephritis associated pulmonary sarcoidosis

Paydas S., ABAYLI B., KOCABAS A., HASTURK S., GONLUSEN G.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.13, sa.1, ss.228-229, 1998 (SCI-Expanded, Scopus)

20. Türkiye’xxde Sigara İçme Davranışını Etkileyen Sosyo-Demografik Faktörler

KOCABAŞ A., BURGUT H. R., BOZDEMİR N.

Solunum Hastalıkları , cilt.5, sa.3, ss.375-386, 1994 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 12

1. Determination of Attitudes of Turkish Thoracic Society Members on Exposure to Sexist Approach and Sexism in Business Life

Ocakli B., Yorgancioglu A., Topcu F., KÖKTÜRK N., Altinoz H., YASIN Y., et al.

28th International Congress of the European-Respiratory-Society (ERS), Paris, Fransa, 15 - 19 Eylül 2018, cilt.52, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

331

H-İndeks (WoS)

Atıf (Scopus)

337

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler